Stock KILITCH KILITCH DRUGS (INDIA) LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Kilitch Drugs (India) Limited

Equities

KILITCH

INE729D01010

Pharmaceuticals

Delayed Bombay S.E.
Other stock markets
 10:50:27 06/05/2024 am IST 		5-day change 1st Jan Change
349.7 INR -0.33% Intraday chart for Kilitch Drugs (India) Limited -5.20% -5.93%
26/02 Kilitch Drugs (India) Unit Bags Supply Contract from Ethiopia MT
23/02 Kilitch Drugs Limited Wins Tender Issued by the Federal Democratic Republic of Ethiopia Pharmaceutical Supply Service for Supply of Pharmaceuticals CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 1,051 3,036 1,254 1,256 2,613 2,175
Enterprise Value (EV) 1 709.8 2,767 1,074 914.9 2,245 1,805
P/E ratio 21.7 x 75.8 x 149 x 34.2 x 35.5 x 20.8 x
Yield 0.63% 0.25% - - - -
Capitalization / Revenue 2.06 x 3.68 x 2.35 x 1.83 x 2.29 x 1.56 x
EV / Revenue 1.39 x 3.35 x 2.01 x 1.34 x 1.96 x 1.29 x
EV / EBITDA 12.4 x 34.3 x 346 x 17.3 x 20.3 x 10.3 x
EV / FCF -17.2 x -15.6 x -13.1 x 9.47 x -6.14 x -24.1 x
FCF Yield -5.81% -6.4% -7.62% 10.6% -16.3% -4.14%
Price to Book 0.97 x 2.51 x 1.06 x 0.99 x 1.88 x 1.43 x
Nbr of stocks (in thousands) 13,232 15,355 15,434 15,495 15,582 15,582
Reference price 2 79.45 197.7 81.25 81.05 167.7 139.6
Announcement Date 07/09/18 05/09/19 07/09/20 04/09/21 03/09/22 02/09/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 510.1 824.9 533.2 685.2 1,142 1,396
EBITDA 1 57.06 80.67 3.108 52.75 110.8 175.6
EBIT 1 45.13 68.7 -8.438 41.34 94.66 148.6
Operating Margin 8.85% 8.33% -1.58% 6.03% 8.29% 10.64%
Earnings before Tax (EBT) 1 61.13 85.87 16.07 51.2 96.14 120.1
Net income 1 51.52 38.3 8.42 36.71 73.67 104.5
Net margin 10.1% 4.64% 1.58% 5.36% 6.45% 7.48%
EPS 2 3.660 2.610 0.5460 2.370 4.730 6.705
Free Cash Flow 1 -41.25 -177.2 -81.85 96.65 -365.3 -74.76
FCF margin -8.09% -21.48% -15.35% 14.1% -31.98% -5.36%
FCF Conversion (EBITDA) - - - 183.22% - -
FCF Conversion (Net income) - - - 263.28% - -
Dividend per Share 2 0.5000 0.5000 - - - -
Announcement Date 07/09/18 05/09/19 07/09/20 04/09/21 03/09/22 02/09/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 341 269 180 341 369 370
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -41.3 -177 -81.8 96.7 -365 -74.8
ROE (net income / shareholders' equity) 4.82% 3.25% 0.69% 3.01% 4.61% 5.7%
ROA (Net income/ Total Assets) 2.34% 3.16% -0.37% 1.49% 2.86% 4.33%
Assets 1 2,197 1,210 -2,287 2,458 2,572 2,415
Book Value Per Share 2 81.60 78.80 76.60 82.00 89.30 97.30
Cash Flow per Share 2 3.480 5.170 1.810 8.070 6.460 12.70
Capex 1 34.9 190 105 363 82 38.1
Capex / Sales 6.84% 23.06% 19.69% 52.97% 7.18% 2.73%
Announcement Date 07/09/18 05/09/19 07/09/20 04/09/21 03/09/22 02/09/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
KILITCH DRUGS (INDIA) LIMITED Stock Kilitch Drugs (India) Limited
-5.93% 67.67M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.08% 662B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. KILITCH Stock
  4. Financials Kilitch Drugs (India) Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW